We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Lack of Cardiovascular Disease Among Old Order Amish With Familial Defective Apolipoprotein B—Reply

Braxton D. Mitchell, MPH, PhD; Haiqing Shen, PhD; Kelsey Shields; Alan R. Shuldiner, MD
Arch Intern Med. 2011;171(11):1039-1040. doi:10.1001/archinternmed.2011.239.
Text Size: A A A
Published online


In reply

Ahmad and Garg have noted the similarity in the proportion of APOB R3500Q carriers and noncarriers with a history of self-reported cardiovascular events and questioned whether the lack of difference could be an artifact of survival bias or alternatively could reflect a lack of association between the mutation and excess cardiovascular morbidity, despite the mutation being associated with increased LDL-C levels and coronary artery calcification. We suspect that the mutation does have an impact on mortality rates based on our preliminary analysis of all-cause mortality in relatives of our study subjects whom we can infer to be mutation carriers. In our Amish population we identified 14 relatives of study subjects (mostly parents) who, although deceased, could unambiguously be inferred as APOB R3500Q carriers. The mean (SD) age at death in these 14 obligate carriers was 68.6 (15.6) years, with a range of 39 to 90 years. In contrast, we have estimated the mean (SD) age at death among Amish from Lancaster County, Pennsylvania, born between 1908 and 1920 to be 77.6 (13.5) years, based on 539 deaths. While we recognize that the number of deaths we have observed among obligate APOB R3500Q carriers is small, our best guess at present is that the APOB R3500Q mutation probably is associated with decreased lifespan and that the lack of difference in self-reported cardiovascular events observed between R3500Q carriers and noncarriers in our study is probably an artifact of the relatively young age of many of our study subjects and/or a survival bias.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
Is There Potentially Compelling Evidence for a Class Effect?

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
Are the End Points in Randomized Clinical Trials Important to Patients?